Marcia Belvin - Net Worth and Insider Trading
Marcia Belvin Net Worth
The estimated net worth of Marcia Belvin is at least $196,726 dollars as of 2024-10-04. Marcia Belvin is the SVP, Chief Scientific Officer of CytomX Therapeutics Inc and owns about 175,648 shares of CytomX Therapeutics Inc (CTMX) stock worth over $196,726. Details can be seen in Marcia Belvin's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Marcia Belvin has not made any transactions after 2024-08-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Marcia Belvin
Marcia Belvin Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Marcia Belvin owns 1 companies in total, including CytomX Therapeutics Inc (CTMX) .
Click here to see the complete history of Marcia Belvin’s form 4 insider trades.
Insider Ownership Summary of Marcia Belvin
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CTMX | CytomX Therapeutics Inc | 2024-08-20 | SVP & Chief Scientific Officer |
Marcia Belvin Latest Holdings Summary
Marcia Belvin currently owns a total of 1 stock. Marcia Belvin owns 175,648 shares of CytomX Therapeutics Inc (CTMX) as of August 20, 2024, with a value of $196,726.
Latest Holdings of Marcia Belvin
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CTMX | CytomX Therapeutics Inc | 2024-08-20 | 175,648 | 1.12 | 196,726 |
Holding Weightings of Marcia Belvin
Marcia Belvin Form 4 Trading Tracker
According to the SEC Form 4 filings, Marcia Belvin has made a total of 4 transactions in CytomX Therapeutics Inc (CTMX) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in CytomX Therapeutics Inc is the sale of 4,181 shares on August 20, 2024, which brought Marcia Belvin around $5,143.
Insider Trading History of Marcia Belvin
- 1
Marcia Belvin Trading Performance
Marcia Belvin Ownership Network
Marcia Belvin Owned Company Details
What does CytomX Therapeutics Inc do?
Who are the key executives at CytomX Therapeutics Inc?
Marcia Belvin is the SVP & Chief Scientific Officer of CytomX Therapeutics Inc. Other key executives at CytomX Therapeutics Inc include SVP & Finance and Accounting Christopher Ogden , Chief Financial Officer Jeffrey B Landau , and General Counsel Lloyd A Rowland .
CytomX Therapeutics Inc (CTMX) Insider Trades Summary
Over the past 18 months, Marcia Belvin made 4 insider transaction in CytomX Therapeutics Inc (CTMX) with a net sale of 25,172. Other recent insider transactions involving CytomX Therapeutics Inc (CTMX) include a net sale of 62,273 shares made by Sean A. Mccarthy , a net sale of 19,012 shares made by Lloyd A Rowland , and a net sale of 18,939 shares made by Jeffrey B Landau .
In summary, during the past 3 months, insiders sold 28,425 shares of CytomX Therapeutics Inc (CTMX) in total and bought 0 shares, with a net sale of 28,425 shares. During the past 18 months, 132,341 shares of CytomX Therapeutics Inc (CTMX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 132,341 shares.
CytomX Therapeutics Inc (CTMX)'s detailed insider trading history can be found in Insider Trading Tracker table.
CytomX Therapeutics Inc Insider Transactions
Marcia Belvin Mailing Address
Above is the net worth, insider trading, and ownership report for Marcia Belvin. You might contact Marcia Belvin via mailing address: C/o Cytomx Therapeutics, Inc., 151 Oyster Point Blvd., Ste. 400, South San Francisco Ca 94080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
